Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$10.01 -2.2%	$10.72	$4.88 ▼ $14.54	$1.44B	1.2	2.01 million shs	4.75 million shs
ATRC AtriCure	$31.59 +0.9%	$37.09	$18.94 ▼ $43.11	$1.54B	1.65	669,398 shs	691,036 shs
IART Integra LifeSciences	$19.58 +0.1%	$23.23	$16.81 ▼ $34.79	$1.51B	1.24	1.04 million shs	770,282 shs
ITGR Integer	$112.79 -0.8%	$127.39	$107.11 ▼ $146.36	$3.79B	1.09	332,968 shs	703,555 shs

20 Stocks to Sell Now

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	-2.15%	-1.28%	-4.30%	+7.06%	-27.46%
ATRC AtriCure	+0.89%	-2.08%	-8.49%	-3.39%	+20.30%
IART Integra LifeSciences	+0.05%	-10.96%	-14.87%	-11.60%	-42.41%
ITGR Integer	-0.95%	-4.37%	-7.27%	-14.71%	-1.89%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATEC Alphatec	3.7621 of 5 stars	3.4	1.0	3.3	2.0	4.2	0.6
ATRC AtriCure	3.4597 of 5 stars	4.5	3.0	0.0	2.9	2.5	0.6
IART Integra LifeSciences	3.4047 of 5 stars	1.9	1.0	4.0	2.8	1.7	2.5
ITGR Integer	2.1651 of 5 stars	3.4	1.0	0.0	2.9	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEC Alphatec	2.89	Moderate Buy	$17.67	76.49% Upside
ATRC AtriCure	3.00	Buy	$49.44	56.52% Upside
IART Integra LifeSciences	1.89	Reduce	$23.00	17.47% Upside
ITGR Integer	2.78	Moderate Buy	$148.56	31.71% Upside

Current Analyst Ratings Breakdown

Latest IART, ITGR, ATRC, and ATEC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/31/2025	IART Integra LifeSciences	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
3/28/2025	ATRC AtriCure	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$66.00 ➝ $52.00
3/28/2025	ITGR Integer	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$145.00
3/27/2025	ATRC AtriCure	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/27/2025	ATRC AtriCure	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$51.00 ➝ $46.00
3/27/2025	ATRC AtriCure	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$51.00 ➝ $51.00
3/21/2025	ATRC AtriCure	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$51.00 ➝ $51.00
2/27/2025	ATEC Alphatec	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$12.00 ➝ $13.00
2/27/2025	ATEC Alphatec	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00 ➝ $16.00
2/21/2025	ITGR Integer	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$140.00 ➝ $150.00
2/21/2025	ITGR Integer	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform

(Data available from 4/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEC Alphatec	$611.56M	2.36	N/A	N/A	$0.57 per share	17.56
ATRC AtriCure	$465.31M	3.32	N/A	N/A	$9.46 per share	3.34
IART Integra LifeSciences	$1.61B	0.94	$4.29 per share	4.56	$20.31 per share	0.96
ITGR Integer	$1.72B	2.21	$7.43 per share	15.18	$48.27 per share	2.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEC Alphatec	-$186.64M	-$1.14	N/A	N/A	N/A	-31.06%	-541.39%	-22.99%	5/6/2025 (Estimated)
ATRC AtriCure	-$44.70M	-$0.95	N/A	N/A	N/A	-9.61%	-6.80%	-5.19%	4/29/2025 (Estimated)
IART Integra LifeSciences	$67.74M	-$0.09	N/A	7.83	0.73	-0.42%	12.35%	4.82%	5/5/2025 (Estimated)
ITGR Integer	$90.65M	$3.36	33.57	16.96	1.72	6.92%	11.65%	5.89%	4/24/2025 (Estimated)

Latest IART, ITGR, ATRC, and ATEC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2025	N/A	ATEC Alphatec	-$0.12	N/A	N/A	N/A	$167.57 million	N/A
5/5/2025	N/A	IART Integra LifeSciences	$0.43	N/A	N/A	N/A	$381.17 million	N/A
4/24/2025	N/A	ITGR Integer	$1.28	N/A	N/A	N/A	$428.51 million	N/A
2/26/2025	Q4 2024	ATEC Alphatec	-$0.19	-$0.23	-$0.04	-$0.23	$172.74 million	$176.79 million
2/25/2025	Q4 2024	IART Integra LifeSciences	$0.85	$0.97	+$0.12	$0.25	$445.15 million	$442.65 million
2/20/2025	Q4 2024	ITGR Integer	$1.46	$1.43	-$0.03	$0.90	$446.28 million	$449.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
ATRC AtriCure	N/A	N/A	N/A	N/A	N/A
IART Integra LifeSciences	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEC Alphatec	30.21	2.32	1.15
ATRC AtriCure	0.13	3.65	2.62
IART Integra LifeSciences	0.79	1.20	0.73
ITGR Integer	0.62	2.95	2.09

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEC Alphatec	66.35%
ATRC AtriCure	99.11%
IART Integra LifeSciences	84.78%
ITGR Integer	99.29%

Insider Ownership

Company	Insider Ownership
ATEC Alphatec	22.80%
ATRC AtriCure	3.20%
IART Integra LifeSciences	3.10%
ITGR Integer	2.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEC Alphatec	700	144.15 million	109.48 million	Optionable
ATRC AtriCure	1,300	48.88 million	47.32 million	Optionable
IART Integra LifeSciences	3,720	77.22 million	74.77 million	Optionable
ITGR Integer	10,500	33.62 million	32.87 million	Optionable

IART, ITGR, ATRC, and ATEC Headlines

Recent News About These Companies

Riverwater Partners LLC Invests $1.59 Million in Integer Holdings Co. (NYSE:ITGR)

April 7 at 5:42 AM | marketbeat.com

Integer Holdings Co. (NYSE:ITGR) Given Average Rating of "Moderate Buy" by Brokerages

April 7 at 2:07 AM | marketbeat.com

Orion Portfolio Solutions LLC Sells 3,073 Shares of Integer Holdings Co. (NYSE:ITGR)

April 6 at 3:51 AM | marketbeat.com

Integer Holdings Co. (NYSE:ITGR) Short Interest Update

April 4, 2025 | marketbeat.com

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio

April 3, 2025 | zacks.com

Vanguard Group Inc. Raises Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

April 3, 2025 | marketbeat.com

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

April 2, 2025 | globenewswire.com

Here's Why Integer (ITGR) is a Strong Momentum Stock

April 2, 2025 | zacks.com

Integer Holdings Co. (NYSE:ITGR) Stock Position Reduced by Prudential Financial Inc.

April 2, 2025 | marketbeat.com

KLP Kapitalforvaltning AS Acquires New Holdings in Integer Holdings Co. (NYSE:ITGR)

April 2, 2025 | marketbeat.com

Integer Holdings Co. (NYSE:ITGR) Shares Sold by Pictet Asset Management Holding SA

April 1, 2025 | marketbeat.com

Artisan Partners Limited Partnership Invests $22.78 Million in Integer Holdings Co. (NYSE:ITGR)

March 30, 2025 | marketbeat.com

Estimating The Intrinsic Value Of Integer Holdings Corporation (NYSE:ITGR)

March 29, 2025 | finance.yahoo.com

Raymond James Initiates Coverage on Integer (NYSE:ITGR)

March 29, 2025 | marketbeat.com

Integer (NYSE:ITGR) Now Covered by Raymond James

March 29, 2025 | americanbankingnews.com

Integer initiated with an Outperform at Raymond James

March 28, 2025 | markets.businessinsider.com

Raymond James Initiates Coverage of Integer Holdings (ITGR) with Outperform Recommendation

March 28, 2025 | msn.com

Here's Why Integer (ITGR) is a Strong Value Stock

March 28, 2025 | zacks.com

Loomis Sayles & Co. L P Purchases 20,688 Shares of Integer Holdings Co. (NYSE:ITGR)

March 28, 2025 | marketbeat.com

Integer Schedules First Quarter 2025 Earnings [...]

March 27, 2025 | aktiencheck.de

Integer Schedules First Quarter 2025 Earnings Release and Conference Call for April 24, 2025

March 27, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART, ITGR, ATRC, and ATEC Company Descriptions

Alphatec NASDAQ:ATEC

$10.01 -0.22 (-2.15%)

Closing price 04/7/2025 04:00 PM Eastern

Extended Trading

$10.01 0.00 (0.00%)

As of 04/7/2025 07:48 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

AtriCure NASDAQ:ATRC

$31.59 +0.28 (+0.89%)

Closing price 04/7/2025 04:00 PM Eastern

Extended Trading

$31.60 +0.02 (+0.05%)

As of 04/7/2025 04:20 PM Eastern

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Integra LifeSciences NASDAQ:IART

$19.58 +0.01 (+0.05%)

Closing price 04/7/2025 04:00 PM Eastern

Extended Trading

$19.59 +0.01 (+0.05%)

As of 04/7/2025 05:30 PM Eastern

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integer NYSE:ITGR

$112.79 -0.91 (-0.80%)

Closing price 04/7/2025 03:59 PM Eastern

Extended Trading

$112.90 +0.10 (+0.09%)

As of 04/7/2025 04:20 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time